for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Australia's drug regulator approves Pfizer COVID-19 vaccine for 12 to 15-year-olds

SYDNEY, July 23 (Reuters) - Australia’s drug regulator has approved Pfizer’s COVID-19 vaccine for use with 12 to 15-year-olds, Federal Health Minister Greg Hunt said on Friday, as the country fights an outbreak of the Delta variant in three states.

The Therapeutic Goods Administration has thoroughly assessed the domestic and international evidence before extending its approval for the Pfizer vaccine to be administered to this age group, Hunt said in a statement.

Similar clearances for the use of the vaccine in children were approved several weeks ago by regulators in the United States, European Union and Britain.

Up until now, the Pfizer vaccine had only been approved for use in Australia for people aged 16 years and over.

Australia’s vaccination panel will advise on which groups of children should be prioritised for the rollout of the vaccine and when it should be administered, Hunt said.

With just over 32,400 COVID-19 cases and 915 deaths, Australia has handled the pandemic much better than many other developed economies, but stop-and-start lockdowns and a sluggish vaccine rollout have led to frustration.

Prime Minister Scott Morrison on Thursday apologised for the slow vaccination programme as his government looks to speed up inoculations and meet a target to vaccinate the adult population by end-2021.

So far, just under 15% of the adult population has been fully vaccinated.

Reporting by Renju Jose; editing by Richard Pullin

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up